Global Psychedelics Therapeutic Market

A new analysis of the global market for psychedelics performed by Brandessence Market Research shows an expected growth from 2022’s $4.87 billion to an annual valuation of nearly $12 billion before 2030. According to the report, the market for psychedelic drugs used for therapeutic purposes -...

Kaya Holdings Inc., (OTCQB: KAYS), also known as “KAYS,” holder and operator of U.S cannabis licenses in all plant-touching categories, initiated the process of seeking the requisite licenses to manufacture psilocybin and set up facilitation service centers in Oregon. As...